2OL3
| crystal structure of BM3.3 ScFV TCR in complex with PBM8-H-2KBM8 MHC class I molecule | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, ALLOGENEIC H-2KBM8 MHC CLASS I MOLECULE, BM3.3 T-CELL RECEPTOR ALPHA-CHAIN, ... | 著者 | Mazza, C, Auphan-Anezin, N, Gregoire, C, Guimezanes, A, Kellenberger, C, Roussel, A, Kearney, A, Van der Merwe, P.A, Schmitt-Verhulst, A.M, Malissen, B. | 登録日 | 2007-01-18 | 公開日 | 2007-04-03 | 最終更新日 | 2023-08-30 | 実験手法 | X-RAY DIFFRACTION (2.9 Å) | 主引用文献 | How much can a T-cell antigen receptor adapt to structurally distinct antigenic peptides? Embo J., 26, 2007
|
|
1T6W
| RATIONAL DESIGN OF A CALCIUM-BINDING ADHESION PROTEIN NMR, 20 STRUCTURES | 分子名称: | CALCIUM ION, hypothetical protein XP_346638 | 著者 | Yang, W, Wilkins, A.L, Ye, Y, Liu, Z.-R, Urbauer, J.L, Kearney, A, van der Merwe, P.A, Yang, J.J. | 登録日 | 2004-05-07 | 公開日 | 2005-02-15 | 最終更新日 | 2021-10-27 | 実験手法 | SOLUTION NMR | 主引用文献 | Design of a calcium-binding protein with desired structure in a cell adhesion molecule. J.Am.Chem.Soc., 127, 2005
|
|
2DRU
| Crystal structure and binding properties of the CD2 and CD244 (2B4) binding protein, CD48 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, GLYCEROL, chimera of CD48 antigen and T-cell surface antigen CD2 | 著者 | Evans, E.J, Ikemizu, S, Davis, S.J. | 登録日 | 2006-06-15 | 公開日 | 2006-07-04 | 最終更新日 | 2023-10-25 | 実験手法 | X-RAY DIFFRACTION (2.6 Å) | 主引用文献 | Crystal Structure and Binding Properties of the CD2 and CD244 (2B4)-binding Protein, CD48 J.Biol.Chem., 281, 2006
|
|
2CLV
| MHC Class I Natural Mutant H-2Kbm8 Heavy Chain Complexed With beta-2 Microglobulin and pBM8 peptide | 分子名称: | BETA-2 MICROGLOBULIN, H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B ALPHA CHAIN, ... | 著者 | Mazza, C, Auphan-Anezin, N, Guimezanes, A, Barrett-Wilt, G.A, Montero-Julian, F, Roussel, A, Hunt, D.F, Schmitt-Verhulst, A.M, Malissen, B. | 登録日 | 2006-05-02 | 公開日 | 2006-06-14 | 最終更新日 | 2023-12-13 | 実験手法 | X-RAY DIFFRACTION (1.9 Å) | 主引用文献 | Distinct orientation of the alloreactive monoclonal CD8 T cell activation program by three different peptide/MHC complexes. Eur. J. Immunol., 36, 2006
|
|